articleGastroenterologyMar 31, 2004Closed access

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆

Osaka University · Tokyo Yamate Medical Center · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

638
total citations
FWCI
13.83
Percentile
100%
References
26
Citations per year

Authors

10

Topics & keywords

Keywords
  • Medicine
  • Placebo
  • Crohn's disease
  • Regimen
  • Internal medicine
  • Gastroenterology
  • Monoclonal antibody
  • Clinical endpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.